Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisense oligonucleotides

N Kashihara1, Y Maeshima, H Makino

  • 1Department of Medicine III, Okayama University Medical School, Japan. kashinao@med.okayama-u.ac.jp

Experimental Nephrology
|April 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum leptin concentrations in patients on hemodialysis.

Nephron·1998
Same author

Newly diagnosed insulin-dependent diabetes mellitus with rapid severe thickening of the glomerular basement membrane.

Nephron·1998
Same author

[Evaluation of hepatic arterial infusion chemotherapy using reservoir for liver metastases from gastric cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·1998
Same author

Studies on disease-modifying antirheumatic drugs. II. Synthesis and activity of the metabolites of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quino line-3-carboxylate (TAK-603).

Chemical & pharmaceutical bulletin·1998
Same author

Accumulation of Nsigma-(carboxy-methyl)lysine and changes in glomerular extracellular matrix components in Otsuka Long-Evans Tokushima fatty rat: a model of spontaneous NIDDM.

Nephron·1998
Same author

Dynamic analysis on rupture of glomerular basement membranes in glomerulonephritis.

Nephron·1998

Antisense technology uses complementary oligonucleotides to inhibit gene expression by degrading messenger RNA (mRNA). This method, primarily involving RNase H, aids in understanding gene function and holds therapeutic potential.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Oligonucleotide Therapeutics

Background:

  • Antisense technology offers a method to control gene expression.
  • Oligonucleotides complementary to messenger RNA (mRNA) are key components.
  • Understanding the mechanisms of action is crucial for application.

Purpose of the Study:

  • To explain the principles of antisense technology.
  • To highlight the role of mRNA degradation in gene inhibition.
  • To discuss the potential therapeutic applications of antisense oligonucleotides.

Main Methods:

  • Utilizing antisense oligonucleotides designed to be complementary to target mRNA.
  • Investigating the mechanisms of gene expression inhibition.
  • Focusing on the role of RNase H in mRNA degradation.

Related Experiment Videos

Main Results:

  • Antisense oligonucleotides effectively inhibit gene expression.
  • Degradation of mRNA by RNase H is identified as a major inhibitory mechanism.
  • The technology can be used for both research and potential therapeutic purposes.

Conclusions:

  • Antisense technology provides a powerful tool for gene expression modulation.
  • RNase H-mediated mRNA degradation is a primary mechanism for antisense effects.
  • Careful design is essential for realizing the therapeutic potential of antisense oligonucleotides.